Type 2 Diabetes
Conditions
Brief summary
The main purpose of this study is to explore experiences and understand the unmet needs of people with Type 2 Diabetes (T2D) among those who are being managed with basal insulin and those who are insulin naïve in order to understand perspectives for a once weekly insulin option; including any potential barriers to being managed with insulin therapy overall. Study participants will be recruited to complete a 15-minute self-administered online survey.
Interventions
OTHERNo treatment given
No treatment given
Sponsors
Novo Nordisk A/S
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Inclusion criteria
1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol). 2. Male or female, age above or equal between 18 to 65 years at the time of signing informed consent. 3. Diagnosed with T2D and currently treating T2D with at least one medication 4. Insulin user that is not using insulin pump 5. Lives in a target country
Exclusion criteria
1. Previous participation in this study. Participation is defined as having given informed consent in this study 2. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation 3. Does not meet inclusion criteria requirements
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Current medication burden | At the time of survey response (Day1) | Numerical; Multiple select from defined list |
| Injection perceptions | At the time of survey response (Day1) | Likert scale for measurement of agreement from 1 strongly disagree to 7 strongly agree |
| Attitudes regarding T2D overall | At the time of survey response (Day1) | Likert scale for measurement of agreement from 1 strongly disagree to 7 strongly agree |
| Attitudes regarding T2D treatment | At the time of survey response (Day1) | Likert scales for measurement of satisfaction from 1 extremely unsatisfied to 7 extremely satisfied and agreement from 1 strongly disagree to 7 strongly agree |
| Attitudes regarding insulin icodec | At the time of survey response (Day1) | Likert scales for measurement of likelihood from 0 not at all likely to 10 extremely likely and agreement from 1 strongly disagree to 7 strongly agree; Rank top 3 from defined list |
Countries
Australia, France, India, Mexico, Saudi Arabia, South Korea, United Kingdom
Outcome results
None listed